Medication | Timing of prescription dispensation (s) | ||||
90 days before LMP | Anytime during pregnancy | First trimester | Second trimester | Third trimester | |
axSpA (n=2410) | |||||
Biological DMARDs (%) | 1.6 | 1.1 | 1.0 | 0.8 | 0.5 |
Conventional synthetic DMARDs (%) | 0.4 | 0.2 | 0.2 | 0.2 | 0.04 |
NSAIDs (%) | 0.3 | 0.2 | 0.2 | 0.1 | 0 |
Corticosteroids (%) | 0.8 | 0.3 | 0.3 | 0.1 | 0.04 |
Opioids (%) | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 |
RA/PsA (n=1721) | |||||
Biological DMARDs (%) | 11.9 | 6.9 | 6.6 | 4.4 | 2.6 |
Conventional synthetic DMARDs (%) | 4.1 | 1.9 | 1.1 | 1.1 | 0.5 |
NSAIDs (%) | 3.8 | 1.3 | 1.1 | 0.6 | 0.3 |
Corticosteroids (%) | 4.4 | 2.2 | 1.2 | 1.4 | 1.1 |
Opioids (%) | 1.1 | 0.6 | 0.1 | 0.3 | 0.4 |
axSpA, axial spondyloarthritis; DMARD, disease-modifying antirheumatic drug; LMP, last menstrual period; NSAID, non-steroidal anti-inflammatory drug; PsA, psoriatic arthritis; RA, rheumatoid arthritis.